Developer docs
API playgroundTry for free, no card

Search company profiles

Crisci Group

Full company profile

uuid0047obb

Namestring
Crisci Group
Legal namestring
Crisci Group
Websiteurl
criscigroup.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Crisci Group is a vertically integrated Australian healthcare and innovative pharmaceutical group, founded in 1998 and headquartered in Glynde, South Australia. The group operates close to 200 staff across 12 locations spanning South Australia, Queensland, Victoria, and New South Wales (most recently Byron Bay, opened February 2026). Its portfolio covers retail pharmacy (Priceline Pharmacy Firle), personalised compounding pharmacy (Cann Compounding, IWG Compounding QLD, Infinity Compounding Pharmacy), TGA-licensed GMP manufacturing (IWG Pharma International), medicinal cannabis dispensaries with integrated on-site clinics (Releaf Dispensaries across VIC, QLD, and NSW), practitioner-led wellness and longevity medicine (Infinity Wellness Group, Integrative Health Solutions), telehealth and clinical services through the Flora Holdings joint venture with ASX-listed Vitura Health, pharmacist-developed skin care and topical formulations, clinical governance and education (ACETC), and internal IT for health and wellness businesses (Genie Tech Solutions).

The underlying technology is an integrated pharmacy, pharmaceutical manufacturing, and wellness platform rather than a discrete software product. Proprietary internal IT infrastructure supports dispensing, compounding, and manufacturing workflows with secure data management, traceability, regulatory reporting, and quality control. Clinical governance and TGA/ARTG compliance frameworks underpin compounding and manufacturing operations. Cann Compounding and Infinity Wellness Group hold LegitScript certification, a credential earned by only a small cohort of healthcare providers globally.

Crisci Group makes money through transaction-fee revenue across six streams: pharmacy dispensing, compounding services, GMP manufacturing (including export-ready supply chains), wellness and longevity consultations, medicinal cannabis dispensary sales, and telehealth/clinic services. Pricing is consultation-based rather than publicly disclosed. Go-to-market combines direct patient-facing pharmacy and dispensary services nationwide, B2B engagement with healthcare practitioners for compounding and emerging-therapy referrals, community-led brand building through charity events and the Little Heroes Foundation partnership, and a sales-led expansion model anchored on the Flora Holdings JV and ongoing clinic acquisitions.

Short descriptiontext

Crisci Group is a vertically integrated Australian healthcare and pharmaceutical group operating compounding pharmacy, GMP manufacturing, retail pharmacy (Priceline), medicinal cannabis dispensaries, wellness clinics, and telehealth across 12 locations in four states, serving patients and healthcare practitioners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGlynde, Australia
HQ citystring
Glynde
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices12 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
compounding pharmacy services, GMP pharmaceutical manufacturing, medicinal cannabis dispensaries, health and wellness consultations, retail pharmacy dispensing
Industry1 code
PRIMARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
NAICS code1 code
  • Pharmacies and Drug Retailers456110
SIC code2 codes
  • Retail-Drug Stores And Proprietary Stores5912
  • Pharmaceutical Preparations2834
Product category
Compounding Pharmacy & Healthcare Services
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model6 records
1Pharmacy Dispensing
TypeTransaction Fee
Description

Dispensing of commercially available medicines through Priceline Pharmacy Firle and other retail pharmacy locations

criscigroup.com
2Compounding Services
TypeTransaction Fee
Description

Personalised compounding pharmacy services for alternative medicines and tailored formulations through Cann Compounding and Infinity Compounding Pharmacy

criscigroup.com
3GMP Manufacturing
TypeTransaction Fee
Description

GMP-certified manufacturing of pharmaceutical-grade products and novel compounds for domestic and international supply chains through IWG Pharma International and Cann Pharma

criscigroup.com
4Health, Wellness & Longevity
TypeTransaction Fee
Description

Practitioner-led wellness consultations, health services, and evidence-based formulations through Infinity Wellness Group and Integrative Health Solutions

criscigroup.com
5Medicinal Cannabis Dispensaries
TypeTransaction Fee
Description

Releaf Dispensary network providing patient support for alternative medicines dosing and product selection across VIC, QLD, and NSW

criscigroup.com
6Telehealth & Clinic Services
TypeTransaction Fee
Description

Face-to-face and telehealth clinical services through Releaf Clinics and Flora Holdings network (including Heyday Medical and Ananda Clinic acquisitions)

criscigroup.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Pricing details1 tier
1Consultation-based pricing for pharmacy and healthcare services
ModelOtherBilling cadencePay-as-you-go
Notes

Services priced through individual consultation; compounding formulations vary by prescription and patient requirements

criscigroup.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Crisci Group is a vertically integrated Australian healthcare and pharmaceutical group that operates compounding pharmacies (Cann Compounding, Infinity Compounding Pharmacy, IWG Compounding QLD), a TGA-licensed GMP manufacturing facility (IWG Pharma International), medicinal cannabis dispensaries with on-site clinics (Releaf), a retail pharmacy (Priceline Pharmacy Firle), and practitioner-led wellness and longevity clinics (IWG/Infinity Wellness Group). The group delivers personalised compounded medicines, pharmaceutical-grade novel compounds, medicinal cannabis dispensing, dispensing of commercial medicines, and evidence-based wellness consultations across 12 locations in Australia, supported by an in-house clinical governance framework and customised IT infrastructure.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 20,000 patients supported in first year at Cann Compounding Adelaide
+4 more records
Product overview1 text field

Crisci Group is a vertically integrated Australian healthcare and innovative pharmaceutical group operating a multi-brand portfolio rather than a single unified product. The group encompasses four core service areas: Pharmacy & Compounded Therapies (delivering personalized compounding and medicine dispensing), GMP Manufacturing & Novel Compounds (pharmaceutical-grade production), Health, Wellness & Longevity (practitioner-led consultations), and Skin Care & Topical Formulations (pharmacist-developed skincare). These services are delivered through specialized sub-brands including Cann Health Group (encompassing Cann Compounding and Cann Pharma), Releaf Dispensaries (integrated clinic and pharmacy locations), IWG/Infinity Wellness Group (multidisciplinary wellness), IWG Compounding QLD, IWG Pharma International, Priceline Pharmacy Firle, Australasian Compounders and Emerging Therapies Corporation (ACETC), and Genie Tech Solutions (IT solutions). The group employs close to 200 staff across 12 locations spanning South Australia, Queensland, Victoria, and New South Wales.

Product and service8 records
1Cann Health Group
CategoryMedicinal Cannabis & Compounding
Description

Parent sub-brand within Crisci Group bringing together Cann Compounding for personalised medicinal cannabis treatment and Cann Pharma for GMP-certified manufacturing of cannabis-based pharmaceutical products, serving patients, practitioners and pharmaceutical partners.

2Cann Compounding
CategoryCompounding Pharmacy
Description

Australia's largest compounding pharmacy for alternative medicines, offering personalised treatment and customised dosage forms for individual patients and healthcare practitioners.

3Releaf Dispensaries
CategoryMedicinal Cannabis Dispensary Network
Description

Dispensary network across Victoria, Queensland and New South Wales providing patient support for alternative medicines dosing and product selection, with integrated on-site clinics for streamlined consultations.

4IWG (Infinity Wellness Group)
CategoryHealth, Wellness & Longevity
Description

Multidisciplinary health and wellness group offering an extensive range of wellness products and services, including practitioner-led wellness consultations and evidence-based formulations for preventative health, performance and longevity medicine.

5IWG Compounding QLD
CategoryCompounding Pharmacy
Description

Premium 600-square-foot compounding laboratory in Queensland dedicated to expanding delivery of high-quality, customised pharmaceutical solutions to the Queensland market for practitioners and patients.

6IWG Pharma International
CategoryGMP Pharmaceutical Manufacturing
Description

Australian TGA-licensed facility manufacturing ARTG Listed dosage forms, complementary medicines and food-based supplements for domestic and international pharmaceutical industry partners.

7Priceline Pharmacy Firle
CategoryRetail Pharmacy
Description

Retail pharmacy in Firle, South Australia offering an extensive range of prescription medicines, cosmetics and healthcare products with award-winning customer service and online e-commerce fulfilment.

8Genie Tech Solutions
CategoryHealth Technology Services
Description

Technology subsidiary providing customised IT solutions to help health and wellness businesses thrive, leveraging internal technology capabilities developed for the Crisci Group network.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1HeyDay Medical
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-04-11
Description

Cann Compounding and HeyDay Medical jointly nominated for Industry Collaboration at the 2025 Cannabiz Awards, reflecting a collaborative partnership in advancing patient care through medicinal cannabis and alternative therapies.

criscigroup.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-19
Description

Flora Holdings joint venture between Crisci Group and Vitura Health (50% interest each) to operate Releaf Dispensaries and Clinics network. The joint venture acquired Releaf Group Limited assets and is expanding the dispensary network nationally. The JV combines Crisci Group's dispensary operations with Vitura Health's resources to transform the alternative healthcare landscape in Australia.

3ANTG (Ananda Clinic)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-12
Description

Flora Holdings acquired Ananda Clinic from ANTG as part of the expansion of the Releaf Clinic and Dispensary network. The acquisition strengthens patient access to integrative and emerging therapies across Australia through both brick-and-mortar clinics and growing telehealth services.

criscigroup.com
4Heyday Medical Clinic
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-21
Description

Flora Holdings (joint venture between Crisci Group and Vitura Health) acquired key assets of Heyday Medical Clinic, one of Australia's most respected alternative therapy clinics. Heyday Medical has delivered high-quality holistic care to over 5,000 patients since 2020. The acquisition significantly strengthens Flora's clinical network and positions the JV as a national leader in face-to-face and telehealth services.

criscigroup.com
Strategic tierMinorTypeOthersAnnounced on2024-01-01
Description

Crisci Group is a proud supporter of the Little Heroes Foundation, which improves the lives of seriously ill children and their families by funding medical equipment, family support programs and hospital infrastructure. Crisci Group has fundraised through City to Bay Fun Run, June Push up Challenge, movie nights, and sponsorships including the 2025 Melbourne Cup Luncheon. $1 from all Bio-Magnesium sales between July-September 2024 and 2025 were donated to the foundation.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-01-01
Description

Crisci Group operates Priceline Pharmacy Firle as a franchisee under the Priceline brand. The store offers an extensive range of prescription medicines, cosmetics, and healthcare products, benefiting from the national Priceline brand recognition, awards, and customer referral network.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

ASX-listed Australian medicinal cannabis and hemp producer with manufacturing and white-label capabilities. Comparable at the manufacturing and product-formulation layer to Cann Pharma and IWG Compounding, though at smaller scale.

2Chemist Warehouse
TypeBroad incumbent
Description

Largest Australian retail pharmacy chain. Overlaps with Priceline Pharmacy Firle on prescription dispensing and OTC/health retail, but operates at vastly larger national scale — a key competitive reference for Crisci's retail pharmacy leg.

TypeDirect peer
Description

ASX-listed medicinal cannabis producer with TGA-GMP manufacturing and Australian/European distribution. Comparable in GMP manufacturing capabilities, cannabis-based formulations, and practitioner-channel go-to-market.

TypeBroad incumbent
Description

Canada-listed GMP contract manufacturer of cannabis-based pharmaceutical products. Overlaps with IWG Pharma International on GMP contract manufacturing capabilities and export-ready pharmaceutical-grade cannabis production.

TypeDirect peer
Description

ASX-listed alternative healthcare and medicinal cannabis company; operates the Flora Holdings JV with Crisci Group at 50/50, owning Releaf Dispensaries and Clinics. Directly comparable in patient channels, medicinal cannabis SKUs, and clinic/dispensary hybrid model.

TypeOthers
Description

Australian retail pharmacy brand franchisor under which Crisci operates Priceline Pharmacy Firle. Indirect peer as the parent brand relationship influences Crisci's retail pharmacy traffic, pricing, and supplier access.

TypeDirect peer
Description

ASX-listed medicinal cannabis company with patient-facing channels in Australia and the UK. Comparable in medicinal cannabis dispensing, practitioner education, and clinic-style patient access models.

TypeEmerging player
Description

ASX-listed medicinal cannabis and wellness products company focused on Australian and European distribution. Comparable in medicinal cannabis product development, practitioner channels, and wellness positioning.

TypeDirect peer
Description

Australian medicinal cannabis cultivator and product supplier whose Ananda Clinic was acquired by Flora Holdings (Crisci's JV). Overlaps in medicinal cannabis products, prescriber channels, and clinical patient access.

TypeDirect peer
Description

Australian medicinal cannabis producer and GMP manufacturer with global distribution. Comparable in GMP manufacturing, cannabinoid formulation, and practitioner channels; former employer of Crisci's CSO Dr. Kylie O'Brien.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries10 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Crisci Group

Compounding Pharmacy & Healthcare Servicescriscigroup.com

Crisci Group is a vertically integrated Australian healthcare and pharmaceutical group operating compounding pharmacy, GMP manufacturing, retail pharmacy (Priceline), medicinal cannabis dispensaries, wellness clinics, and telehealth across 12 locations in four states, serving patients and healthcare practitioners.

What Crisci Group does

Crisci Group is a vertically integrated Australian healthcare and innovative pharmaceutical group, founded in 1998 and headquartered in Glynde, South Australia. The group operates close to 200 staff across 12 locations spanning South Australia, Queensland, Victoria, and New South Wales (most recently Byron Bay, opened February 2026). Its portfolio covers retail pharmacy (Priceline Pharmacy Firle), personalised compounding pharmacy (Cann Compounding, IWG Compounding QLD, Infinity Compounding Pharmacy), TGA-licensed GMP manufacturing (IWG Pharma International), medicinal cannabis dispensaries with integrated on-site clinics (Releaf Dispensaries across VIC, QLD, and NSW), practitioner-led wellness and longevity medicine (Infinity Wellness Group, Integrative Health Solutions), telehealth and clinical services through the Flora Holdings joint venture with ASX-listed Vitura Health, pharmacist-developed skin care and topical formulations, clinical governance and education (ACETC), and internal IT for health and wellness businesses (Genie Tech Solutions).

The underlying technology is an integrated pharmacy, pharmaceutical manufacturing, and wellness platform rather than a discrete software product. Proprietary internal IT infrastructure supports dispensing, compounding, and manufacturing workflows with secure data management, traceability, regulatory reporting, and quality control. Clinical governance and TGA/ARTG compliance frameworks underpin compounding and manufacturing operations. Cann Compounding and Infinity Wellness Group hold LegitScript certification, a credential earned by only a small cohort of healthcare providers globally.

Crisci Group makes money through transaction-fee revenue across six streams: pharmacy dispensing, compounding services, GMP manufacturing (including export-ready supply chains), wellness and longevity consultations, medicinal cannabis dispensary sales, and telehealth/clinic services. Pricing is consultation-based rather than publicly disclosed. Go-to-market combines direct patient-facing pharmacy and dispensary services nationwide, B2B engagement with healthcare practitioners for compounding and emerging-therapy referrals, community-led brand building through charity events and the Little Heroes Foundation partnership, and a sales-led expansion model anchored on the Flora Holdings JV and ongoing clinic acquisitions.

Crisci Group firmographics

Firmographics
Name
Crisci Group
Legal name
Crisci Group
Website
https://criscigroup.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
11–50 employees
Short description
Crisci Group is a vertically integrated Australian healthcare and pharmaceutical group operating compounding pharmacy, GMP manufacturing, retail pharmacy (Priceline), medicinal cannabis dispensaries, wellness clinics, and telehealth across 12 locations in four states, serving patients and healthcare practitioners.
Ownership category
akta.pro rank

Crisci Group industry classification

Industry
Product category
Compounding Pharmacy & Healthcare Services
NAICS
Pharmacies and Drug Retailers (456110)
SIC
Retail-Drug Stores And Proprietary Stores (5912), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)

Keywords

  • Compounding pharmacy services
  • GMP pharmaceutical manufacturing
  • Medicinal cannabis dispensaries
  • Health and wellness consultations
  • Retail pharmacy dispensing

Where Crisci Group is headquartered

Location

Headquarters

HQ city
Glynde
HQ country
Australia
HQ region
Oceania

Offices12 records

Markets served

Crisci Group business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Pharmacy Dispensing: Dispensing of commercially available medicines through Priceline Pharmacy Firle and other retail pharmacy locations
  2. Compounding Services: Personalised compounding pharmacy services for alternative medicines and tailored formulations through Cann Compounding and Infinity Compounding Pharmacy
  3. GMP Manufacturing: GMP-certified manufacturing of pharmaceutical-grade products and novel compounds for domestic and international supply chains through IWG Pharma International and Cann Pharma
  4. Health, Wellness & Longevity: Practitioner-led wellness consultations, health services, and evidence-based formulations through Infinity Wellness Group and Integrative Health Solutions
  5. Medicinal Cannabis Dispensaries: Releaf Dispensary network providing patient support for alternative medicines dosing and product selection across VIC, QLD, and NSW
  6. Telehealth & Clinic Services: Face-to-face and telehealth clinical services through Releaf Clinics and Flora Holdings network (including Heyday Medical and Ananda Clinic acquisitions)

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goConsultation-based pricing for pharmacy and healthcare services

Go-to-market motion3 records

Distribution channels7 records

Marketing channels7 records

Crisci Group product offering

Product offering

Core offering

Crisci Group is a vertically integrated Australian healthcare and pharmaceutical group that operates compounding pharmacies (Cann Compounding, Infinity Compounding Pharmacy, IWG Compounding QLD), a TGA-licensed GMP manufacturing facility (IWG Pharma International), medicinal cannabis dispensaries with on-site clinics (Releaf), a retail pharmacy (Priceline Pharmacy Firle), and practitioner-led wellness and longevity clinics (IWG/Infinity Wellness Group). The group delivers personalised compounded medicines, pharmaceutical-grade novel compounds, medicinal cannabis dispensing, dispensing of commercial medicines, and evidence-based wellness consultations across 12 locations in Australia, supported by an in-house clinical governance framework and customised IT infrastructure.

Product overview

Crisci Group is a vertically integrated Australian healthcare and innovative pharmaceutical group operating a multi-brand portfolio rather than a single unified product. The group encompasses four core service areas: Pharmacy & Compounded Therapies (delivering personalized compounding and medicine dispensing), GMP Manufacturing & Novel Compounds (pharmaceutical-grade production), Health, Wellness & Longevity (practitioner-led consultations), and Skin Care & Topical Formulations (pharmacist-developed skincare). These services are delivered through specialized sub-brands including Cann Health Group (encompassing Cann Compounding and Cann Pharma), Releaf Dispensaries (integrated clinic and pharmacy locations), IWG/Infinity Wellness Group (multidisciplinary wellness), IWG Compounding QLD, IWG Pharma International, Priceline Pharmacy Firle, Australasian Compounders and Emerging Therapies Corporation (ACETC), and Genie Tech Solutions (IT solutions). The group employs close to 200 staff across 12 locations spanning South Australia, Queensland, Victoria, and New South Wales.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cann Health Group Parent sub-brand within Crisci Group bringing together Cann Compounding for personalised medicinal cannabis treatment and Cann Pharma for GMP-certified manufacturing of cannabis-based pharmaceutical products, serving patients, practitioners and pharmaceutical partners.
  • Cann Compounding Australia's largest compounding pharmacy for alternative medicines, offering personalised treatment and customised dosage forms for individual patients and healthcare practitioners.
  • Releaf Dispensaries Dispensary network across Victoria, Queensland and New South Wales providing patient support for alternative medicines dosing and product selection, with integrated on-site clinics for streamlined consultations.
  • IWG (Infinity Wellness Group) Multidisciplinary health and wellness group offering an extensive range of wellness products and services, including practitioner-led wellness consultations and evidence-based formulations for preventative health, performance and longevity medicine.
  • IWG Compounding QLD Premium 600-square-foot compounding laboratory in Queensland dedicated to expanding delivery of high-quality, customised pharmaceutical solutions to the Queensland market for practitioners and patients.
  • IWG Pharma International Australian TGA-licensed facility manufacturing ARTG Listed dosage forms, complementary medicines and food-based supplements for domestic and international pharmaceutical industry partners.
  • Priceline Pharmacy Firle Retail pharmacy in Firle, South Australia offering an extensive range of prescription medicines, cosmetics and healthcare products with award-winning customer service and online e-commerce fulfilment.
  • Genie Tech Solutions Technology subsidiary providing customised IT solutions to help health and wellness businesses thrive, leveraging internal technology capabilities developed for the Crisci Group network.

Quantifiable outcome

  • Over 20,000 patients supported in first year at Cann Compounding Adelaide
  • +4 more outcomes

Companies that use Crisci Group

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Crisci Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Crisci Group partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • HeyDay MedicalminorStrategic or Co-development Partner · 11 April 2025Cann Compounding and HeyDay Medical jointly nominated for Industry Collaboration at the 2025 Cannabiz Awards, reflecting a collaborative partnership in advancing patient care through medicinal cannabis and alternative therapies.
  • Vitura Health (ASX: VIT)coreStrategic or Co-development Partner · 19 November 2024Flora Holdings joint venture between Crisci Group and Vitura Health (50% interest each) to operate Releaf Dispensaries and Clinics network. The joint venture acquired Releaf Group Limited assets and is expanding the dispensary network nationally. The JV combines Crisci Group's dispensary operations with Vitura Health's resources to transform the alternative healthcare landscape in Australia.
  • ANTG (Ananda Clinic)coreStrategic or Co-development Partner · 12 September 2024Flora Holdings acquired Ananda Clinic from ANTG as part of the expansion of the Releaf Clinic and Dispensary network. The acquisition strengthens patient access to integrative and emerging therapies across Australia through both brick-and-mortar clinics and growing telehealth services.
  • Heyday Medical CliniccoreStrategic or Co-development Partner · 21 May 2024Flora Holdings (joint venture between Crisci Group and Vitura Health) acquired key assets of Heyday Medical Clinic, one of Australia's most respected alternative therapy clinics. Heyday Medical has delivered high-quality holistic care to over 5,000 patients since 2020. The acquisition significantly strengthens Flora's clinical network and positions the JV as a national leader in face-to-face and telehealth services.
  • Little Heroes FoundationminorOthers · 1 January 2024Crisci Group is a proud supporter of the Little Heroes Foundation, which improves the lives of seriously ill children and their families by funding medical equipment, family support programs and hospital infrastructure. Crisci Group has fundraised through City to Bay Fun Run, June Push up Challenge, movie nights, and sponsorships including the 2025 Melbourne Cup Luncheon. $1 from all Bio-Magnesium sales between July-September 2024 and 2025 were donated to the foundation.
  • Priceline PharmacycoreChannel Partner/ Reseller/ Distributor · 1 January 2019Crisci Group operates Priceline Pharmacy Firle as a franchisee under the Priceline brand. The store offers an extensive range of prescription medicines, cosmetics, and healthcare products, benefiting from the national Priceline brand recognition, awards, and customer referral network.

Scale indicators10 records

Recent moves12 records

Expansion highlights6 records

Crisci Group competitors and assessment

Company assessment

Emerging players

  • ECS Botanics: ASX-listed Australian medicinal cannabis and hemp producer with manufacturing and white-label capabilities. Comparable at the manufacturing and product-formulation layer to Cann Pharma and IWG Compounding, though at smaller scale.
  • Bod Australia (now Health House International): ASX-listed medicinal cannabis and wellness products company focused on Australian and European distribution. Comparable in medicinal cannabis product development, practitioner channels, and wellness positioning.

Broad incumbents

  • Chemist Warehouse: Largest Australian retail pharmacy chain. Overlaps with Priceline Pharmacy Firle on prescription dispensing and OTC/health retail, but operates at vastly larger national scale — a key competitive reference for Crisci's retail pharmacy leg.
  • MediPharm Labs: Canada-listed GMP contract manufacturer of cannabis-based pharmaceutical products. Overlaps with IWG Pharma International on GMP contract manufacturing capabilities and export-ready pharmaceutical-grade cannabis production.

Direct peers

  • Little Green Pharma: ASX-listed medicinal cannabis producer with TGA-GMP manufacturing and Australian/European distribution. Comparable in GMP manufacturing capabilities, cannabis-based formulations, and practitioner-channel go-to-market.
  • Vitura Health (formerly Cronos Australia): ASX-listed alternative healthcare and medicinal cannabis company; operates the Flora Holdings JV with Crisci Group at 50/50, owning Releaf Dispensaries and Clinics. Directly comparable in patient channels, medicinal cannabis SKUs, and clinic/dispensary hybrid model.
  • Althea Group Holdings: ASX-listed medicinal cannabis company with patient-facing channels in Australia and the UK. Comparable in medicinal cannabis dispensing, practitioner education, and clinic-style patient access models.
  • ANTG (Australian Natural Therapeutics Group): Australian medicinal cannabis cultivator and product supplier whose Ananda Clinic was acquired by Flora Holdings (Crisci's JV). Overlaps in medicinal cannabis products, prescriber channels, and clinical patient access.
  • Cannim Group: Australian medicinal cannabis producer and GMP manufacturer with global distribution. Comparable in GMP manufacturing, cannabinoid formulation, and practitioner channels; former employer of Crisci's CSO Dr. Kylie O'Brien.

Others

  • Priceline Pharmacy (API / Souls Group): Australian retail pharmacy brand franchisor under which Crisci operates Priceline Pharmacy Firle. Indirect peer as the parent brand relationship influences Crisci's retail pharmacy traffic, pricing, and supplier access.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Crisci Group social profiles

Digital presence

Crisci Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Crisci Group leadership team

Management profile

Number of profiles

Profiles6 records

Crisci Group subsidiaries and ownership

Company hierarchy

Subsidiaries10 records

Crisci Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Crisci Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Crisci Group

What does Crisci Group do?

Crisci Group is a vertically integrated Australian healthcare and pharmaceutical group that operates compounding pharmacies (Cann Compounding, Infinity Compounding Pharmacy, IWG Compounding QLD), a TGA-licensed GMP manufacturing facility (IWG Pharma International), medicinal cannabis dispensaries with on-site clinics (Releaf), a retail pharmacy (Priceline Pharmacy Firle), and practitioner-led wellness and longevity clinics (IWG/Infinity Wellness Group). The group delivers personalised compounded medicines, pharmaceutical-grade novel compounds, medicinal cannabis dispensing, dispensing of commercial medicines, and evidence-based wellness consultations across 12 locations in Australia, supported by an in-house clinical governance framework and customised IT infrastructure.

Is Crisci Group a public or private company?

Crisci Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Crisci Group founded?

Crisci Group was founded in 1998. It employs 11 to 50 people.

Where is Crisci Group based?

Crisci Group is headquartered in Glynde, Australia, in the Oceania region.

How does Crisci Group make money?

Six revenue lines are on record. Pharmacy Dispensing is the primary driver. The others are compounding Services, GMP Manufacturing, health, Wellness & Longevity, medicinal Cannabis Dispensaries and telehealth & Clinic Services.

Who are Crisci Group's main competitors?

Emerging players on record are ECS Botanics and Bod Australia (now Health House International). Broad incumbents are Chemist Warehouse and MediPharm Labs. Direct peers are Little Green Pharma, Vitura Health (formerly Cronos Australia), Althea Group Holdings, ANTG (Australian Natural Therapeutics Group) and Cannim Group. Priceline Pharmacy (API / Souls Group) is listed as an others.

Does Crisci Group have an API?

No public API is recorded for Crisci Group.

What industry is Crisci Group in?

Crisci Group's product category is Compounding Pharmacy & Healthcare Services. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services). Its NAICS code is 456110 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales